Drug Topics
AUGUST 16, 2024
Tom DePietro, PharmD, owner of DePietro’s Pharmacy in Dunmore, Pennsylvania, discussed his experience as an independent pharmacy owner working under the thumb of pharmacy benefit managers.
STAT
AUGUST 15, 2024
WASHINGTON — The day drug makers dreaded has finally arrived. Medicare officials on Thursday unveiled the results of the program’s first 10 drug price negotiations, despite the industry’s two-decade, multimillion-dollar lobbying campaign and barrage of lawsuits to stop them. The drugs that received negotiated prices include Bristol Myers Squibb’s blood thinner Eliquis, Boehringer Ingelheim’s diabetes drug Jardiance, Johnson & Johnson’s bl
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
AUGUST 10, 2024
Non-steroidal mineralocorticoid receptor antagonist, finerenone, demonstrated improved efficacy compared with existing steroidal treatment for patients.
Fierce Healthcare
AUGUST 14, 2024
Entrepreneur and investor Mark Cuban wants to "f--k up" the U.S. healthcare system to make it more affordable, the billionaire told "The Daily Show" host Jon Stewart this week. | Entrepreneur and investor Mark Cuban wants to "f--k up" the U.S. healthcare system to make it more affordable, the billionaire told "The Daily Show" host Jon Stewart this week.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
AUGUST 11, 2024
In case you missed it, this week we had news about opioid prescribing for patients with chronic pain, a possible link between cannabis and cancer, preparing for the upcoming flu season, and more.
STAT
AUGUST 14, 2024
The World Health Organization on Wednesday declared the spread of mpox in multiple African countries a public health emergency of international concern, the second such declaration in the past two years called in response to transmission of the virus. The latest decision came on the recommendation of a panel of experts convened to advise WHO Director-General Tedros Adhanom Ghebreyesus on the issue.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Healthcare
AUGUST 12, 2024
Consumer genetic testing company 23andMe sees an opportunity to get in on the weight loss boom. | 23andMe plans to launch a GLP-1 weight loss telehealth membership through its Lemonaid Health platform by the end of the month.
Drug Topics
AUGUST 13, 2024
Experts analyzed data from the National Center for Health Statistics on the leading causes of death in the US from the last 5 years.
STAT
AUGUST 14, 2024
In February 2021, I received my second Covid-19 shot — the newly developed vaccine that would eventually save millions of lives worldwide — with great anticipation. It proved to be a life-changing event: Two hours later as I was driving home, the shock of a sudden loud and high-pitched whistling nearly caused me to veer off the road. It was as if an audible dog whistle began blaring right next to me.
Pharmacy Times
AUGUST 12, 2024
The trial evaluated a fixed-dose combination of vibostolimab and pembrolizumab in combination with chemotherapy as a first-line treatment for extensive-stage small cell lung cancer.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
AUGUST 14, 2024
Getting seniors enrolled into the right Medicare plan is typically an inefficient process that many older patients find confusing and frustrating, spending hours on the phone with human call center | Startup Fair Square Medicare is using advancements with generative AI to build AI-based voice agents to screen seniors for Medicare coverage and improve the customer experience.
Drug Topics
AUGUST 15, 2024
New prices will go into effect on January 1, 2026, for individuals covered by Medicare Part D prescription drugs.
STAT
AUGUST 16, 2024
Degree by degree, the earth’s temperature ticks up. Heat records fall as reliably as the sun sets. In July, the East Coast broiled. This week, Texas and its neighbors are feeling the burn. It’s been an absolute scorcher in the United States, the hottest summer on record. This summer might also be one of the coolest summers for the rest of your life.
Pharmacy Times
AUGUST 14, 2024
The seroprotection rate of antibody titers was 100% against the 3 viruses, and geometric mean titer also increased from administration to day 43.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
AUGUST 15, 2024
The Centers for Medicare & Medicaid Services offered the first look at the potential savings generated by the first crop of Medicare drug price negotiations. | The Centers for Medicare & Medicaid Services offered the first look at the potential savings generated by the first crop of Medicare drug price negotiations.
Drug Topics
AUGUST 12, 2024
Our congressional representatives have plenty of interaction with PBM lobbyists. It’s time they hear from patients as well.
STAT
AUGUST 11, 2024
The journal Psychopharmacology has retracted three papers about MDMA-assisted psychotherapy — right on the heels of the Food and Drug Administration’s rejection of the closely watched treatment for post-traumatic stress disorder. Many authors on the three studies are affiliated with the nonprofit Multidisciplinary Association for Psychedelic Studies (MAPS) and its commercial spinout Lykos Therapeutics, including founder Rick Doblin, who spearheaded the decades-long efforts to win a
Pharmacy Times
AUGUST 15, 2024
The supplemental biologics license application was granted based on results from the ADRIATIC phase 3 trial among individuals with limited stage small cell lung cancer.
Fierce Healthcare
AUGUST 14, 2024
Startup Abridge has notched it's largest partnership to date as Kaiser Permanente is making its generative AI tools for medical documentation available to more than 24,000 doctors across its system | Startup Abridge has notched it's largest partnership to date as Kaiser Permanente is making its generative AI tools for medical documentation available to more than 24,000 doctors across its system.
Drug Topics
AUGUST 16, 2024
First To Know Syphilis Tests are expected to be available at major national retailers and online in late 2024.
STAT
AUGUST 12, 2024
If you twirl a bottle of alcohol and squint, you might see a text box with a warning. Usually in black and white, with letters two to three millimeters high, it reads: GOVERNMENT WARNING: (1) According to the Surgeon General, women should not drink alcoholic beverages during pregnancy because of the risk of birth defects. (2) Consumption of alcoholic beverages impairs your ability to drive a car or operate machinery, and may cause health problems.
Pharmacy Times
AUGUST 15, 2024
RSV and influenza vaccines demonstrated hemagglutination inhibition titers that were noninferior to those with sequential administration.
Fierce Healthcare
AUGUST 14, 2024
In this week's episode of "Podnosis," we’re discussing the challenges and opportunities for telehealth, given some notable setbacks for the industry in recent months. | In this week's episode of "Podnosis," we’re discussing the challenges and opportunities for telehealth, given some notable setbacks for the industry in recent months.
Drug Topics
AUGUST 13, 2024
Rejoyn, developed by Otsuka Pharmaceutical and Click Therapeutics, is only accessible with a prescription from a health care provider.
STAT
AUGUST 14, 2024
At the start of the clinic where I see patients with colorectal, stomach, pancreatic, and other gastrointestinal cancers, I remarked to a colleague, “Every new patient on my schedule is under 45.” She replied, “Three of mine are … this is too many young people with cancer.” We felt as though we were in the trenches and didn’t know where the bullets were coming from.
Pharmacy Times
AUGUST 15, 2024
Key opinion leaders analyze the efficacy, safety profile, and proper utilization of behind-the-counter medications such as pseudoephedrine products, exploring their mechanisms of action and potential adverse effects, while also providing strategies for pharmacists to identify contraindications, drug interactions, and appropriate dosing regimens for these medications.
Fierce Healthcare
AUGUST 16, 2024
Employers' health costs are expected to rise by an average of 9% next year, according to a new report from Aon. | Employers' health costs are expected to rise by an average of 9% next year, according to a new report from Aon.
Fierce Pharma
AUGUST 14, 2024
With an FDA appro | The FDA has approved Gilead's primary biliary cholangitis treatment Livdelzi. The drug, which was acquired in a $4.3 billion buyout of CymaBay Therapeutics six months ago, is the first inflammatory treatment launched by Gilead.
STAT
AUGUST 16, 2024
When mpox first began to spread internationally in 2022, affected countries scrambled to buy some of the limited supply of poxvirus vaccines produced in the world. The Danish company Bavarian Nordic, maker of the Jynneos smallpox vaccine, faced the sizable challenge of trying to meet demand with its supply. This week’s declaration of a second public health emergency of international concern to deal with new and concerning outbreaks of mpox in Africa has again thrust the company onto cente
Pharmacy Times
AUGUST 14, 2024
Individuals with Parkinson disease reported a decrease in bacterial genes for biosynthesis of riboflavin (vitamin B2) and biotin (vitamin B7).
Fierce Healthcare
AUGUST 13, 2024
Vivid Health is launching into the at-home care market to help clinical staff more efficiently fill out required, but time-consuming, assessment forms, reduce staff burnout and increase c | Digital health startup Vivid Health is a multispecialty care management platform that leverages generative AI to create patient care plans. The solution is particularly well suited for the home health sector, which struggles with capacity and burnout.
Fierce Pharma
AUGUST 13, 2024
When the FDA approved Amgen’s Imdelltra in May, the T-cell engager was hailed as a breakthrough for the treatment of small cell lung cancer (SCLC) and as the first DLL3-targeting therapy of potenti | In granting an accelerated approval to Amgen's first-in-class DLL3 bispecific Imdelltra, the FDA had to work through a “large number” of missing adverse events from a pivotal trial.
STAT
AUGUST 15, 2024
Modern medicine has an empathy problem. Artificial intelligence — done right — might be able to help ease it. Despite the proliferation of communication training programs over the past decade or two, doctors often fail to express empathy, especially in stressful moments when patients and their families are struggling to hear bad news and make difficult decisions.
Pharmacy Times
AUGUST 16, 2024
Olivia Kinney, a national pharmacy practice manager at Kroger, discusses strategies for pharmacists to effectively address vaccine hesitancy by building trust with patients.
Expert insights. Personalized for you.
184 
Let's personalize your content